21
November
2023
|
09:38
Asia/Singapore

The global antibiotic pipeline is running dry. How can Singapore spur new drug development?

By Assoc Prof Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), Assoc Prof Wee Hwee Lin, Director of the Centre for Health Intervention and Policy Evaluation Research; both from the Saw Swee Hock School of Public Health at NUS; and Visiting Prof Joanne Yoong, from the Yong Loo Lin School of Medicine at NUS